BKSY three-lens brief
Evidence-based stock research on BKSY. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 13.5pp over 30 days. · Negative free cash flow last quarterly (-$71.38M).
- Outperforming SPY by 13.5pp over 30 days.
- Analyst mean target $36.38 — 51% above current (8 analysts).
- Negative free cash flow last quarterly (-$71.38M).
- Reported earnings on 2026-11-05.
BKSY closed at $24.10 (+1.09%) as of 2026-11-12. Market cap: $990.55M. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 13.5pp over 30 days.; analyst mean target $36.38 — 51% above current (8 analysts).. Concerns: negative free cash flow last quarterly (-$71.38M).. Last quarter: Revenue $42.84M, net income $18.52M, free cash flow -$71.38M.
Why three lenses on BKSY, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BKSY across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BKSY" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BKSY brief"></iframe>